Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 8-chloro-3-beta-diethylaminoethyl-4-methyl-7-ethyoxycarbonymethoxycoumarin
2. 8-chlorocarbochromen
3. 8-chlorocarbochromen Hydrochloride
4. 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarboxylmethoxycoumarin
5. Ad 6
6. Ad(6)
7. Ad6
8. Cloricromene
1. Cloricromene
2. 68206-94-0
3. 8-chlorocarbochromen
4. Cloricromen [inn]
5. Proendotel
6. Ad-6
7. Acetic Acid, ((8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2h-1-benzopyran-7-yl)oxy)-, Ethyl Ester
8. B9454pe93c
9. Cloricromen (inn)
10. Ethyl ((8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2h-1-benzopyran-7-yl)oxy)acetate
11. Cloricromene [french]
12. Cloricromenum [latin]
13. Cloricromeno
14. Cloricromeno [spanish]
15. Cloricromenum
16. Ad 6 (pharmaceutical)
17. Ethyl [[8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2h-1-benzopyran-7-yl]oxy]acetate
18. Ethyl 2-[8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxochromen-7-yl]oxyacetate
19. Ncgc00165769-02
20. Unii-b9454pe93c
21. Cloricromen [mi]
22. Cloricromen [mart.]
23. Cloricromen [who-dd]
24. Schembl133346
25. Chembl255066
26. Dtxsid2048373
27. Chebi:135628
28. Zinc576842
29. Db13367
30. Ethyl 2-(8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2h-chromen-7-yloxy)acetate
31. Ncgc00165769-01
32. Db-055121
33. Ft-0603198
34. D07139
35. 206c940
36. Q5135145
37. O=c(occ)coc1=cc=c(c(o2)=c1cl)c(c)=c(ccn(cc)cc)c2=o
| Molecular Weight | 395.9 g/mol |
|---|---|
| Molecular Formula | C20H26ClNO5 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 395.1499506 g/mol |
| Monoisotopic Mass | 395.1499506 g/mol |
| Topological Polar Surface Area | 65.1 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 561 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
B - Blood and blood forming organs
B01 - Antithrombotic agents
B01A - Antithrombotic agents
B01AC - Platelet aggregation inhibitors excl. heparin
B01AC02 - Cloricromen
Global Sales Information
ABOUT THIS PAGE
39
PharmaCompass offers a list of Cloricromen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloricromen manufacturer or Cloricromen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloricromen manufacturer or Cloricromen supplier.
PharmaCompass also assists you with knowing the Cloricromen API Price utilized in the formulation of products. Cloricromen API Price is not always fixed or binding as the Cloricromen Price is obtained through a variety of data sources. The Cloricromen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloricromen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloricromen, including repackagers and relabelers. The FDA regulates Cloricromen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloricromen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cloricromen supplier is an individual or a company that provides Cloricromen active pharmaceutical ingredient (API) or Cloricromen finished formulations upon request. The Cloricromen suppliers may include Cloricromen API manufacturers, exporters, distributors and traders.
Cloricromen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloricromen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloricromen GMP manufacturer or Cloricromen GMP API supplier for your needs.
A Cloricromen CoA (Certificate of Analysis) is a formal document that attests to Cloricromen's compliance with Cloricromen specifications and serves as a tool for batch-level quality control.
Cloricromen CoA mostly includes findings from lab analyses of a specific batch. For each Cloricromen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloricromen may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloricromen EP), Cloricromen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloricromen USP).
